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You Can Run, but You Can’t Hide: 
The Academic Physician and 
Molecular Biology 
n this issue of Academic I Emergency Medicine, Drs. 
White and Sullivan provide a 
comprehensive look at apopto- 
sis.’ The article delves deeply 
into the cellular and subcellular 
molecular processes that  contrib- 
ute to “self-destructive cell 
death.” For those academic phy- 
sicians who are too old, or were 
too inattentive, to have received 
proper schooling in molecular bi- 
ology, getting through an  article 
such as this can be a daunting 
task. When I was in medical 
school in the early 198Os, adhe- 
sion molecules were the things 
that made my dirty dishes stick 
together when they piled up in 
the sink, and free radicals were 
non-incarcerated burned-out hip- 
pies. 
The explosion of science in 
the field of molecular biology, 
particularly in the area of cellu- 
lar injury, means that even for 
recent medical school graduates, 
keeping informed involves learn- 
ing new concepts and terminol- 
ogy. Can the academic physician 
be ignorant of the recent ad- 
vances in molecular biology and 
still function well? Perhaps, but 
each year the bar is set higher. 
Learning the basics of apoptosis 
today will make it far easier to 
understand future discoveries in 
molecular biology. 
As one explores the field of 
molecular or cell biology, a pleas- 
ant paradox is found. Although 
the scientific methodology is be- 
coming more complex and tech- 
nical, some unifying themes of 
cellular function can make the 
science easier to understand. For 
all of its complexity, the cell has 
a finite number of ways to re- 
spond to stress. Investigators in 
the seemingly disparate fields of 
infectious disease, cardiac dis- 
ease, stroke, and traumatic in- 
jury find that they are playing 
with the same molecules and 
biomolecular processes. This be- 
came apparent to me in my re- 
search on alcohol intoxication 
and traumatic brain injury, as I 
discovered that cellular reactions 
to a toxin (ethanol) are similar to 
that seen with applied energy 
(traumatic injury). Recognizing 
these similarities is an  impor- 
tant function for the academic 
physician. We tend to become a 
bit resentful of the basic scien- 
tists, tucked away in their labo- 
ratories, churning out volumes of 
biomolecular information that 
we must try to understand. We 
forget that  it is a 2-way street- 
the fuel for molecular biomedical 
research comes from our pa- 
tients’ disease processes and our 
observations of those diseases. 
Communication between biomo- 
lecular researchers and aca- 
demic physicians is mutually 
beneficial-we learn more about 
basic cellular processes, and they 
gain insight into the clinical rel- 
evance and applications of their 
research. 
Even if it  is agreed that phy- 
sicians need to keep abreast of 
the advances in biomolecular sci- 
ence, the logistics of this learn- 
ing can be difficult. Since most of 
us will not have molecular biol- 
ogy journals on our nightstands 
or desks, we rely on review arti- 
cles in our “normal” medical 
journals to provide biomolecular 
updates. A few suggestions for 
approaching such an  article fol- 
low: 
1. You can’t fake the funda- 
mentals. Whether we like it or 
not, a basic understanding of mo- 
lecular biology is requisite to the 
current practice of medicine. Mo- 
lecular biology can be grossly 
subcategorized into the study of 
genes and gene expression, pro- 
teins and protein function, and 
the interaction of other mole- 
cules, cells, and tissues with the 
proteins that are produced as a 
result of gene expression. If one 
has not gained this knowledge 
through medical training, it 
must be acquired, or at least ac- 
cessible, through other means. 
We are fortunate in having more 
learning tools available to us 
than our predecessors, which is 
good, because we have a lot more 
information to digest. A current 
(i.e., not less than 5 years old) 
molecular biology textbook is a 
good place to start. Additionally, 
a number of sources of biomo- 
lecular educational materials for 
physicians are available on CD- 
ROM. Most medical journals, in 
a manner similar to that ofAEM, 
offer review articles that  address 
topics in molecular biology. The 
academic physician who can pe- 
riodically learn the basics of new 
developments in molecular biol- 
ogy, and knows where to search 
for the details, will face fewer 
surprises and less bewilderment 
as new discoveries are made. 
2. Don’t sweat the jargon. Mo- 
lecular biologists seem to have 
trouble with naming things, and 
especially in limiting the number 
of names for each molecule or  
process. Many molecules have 
multiple names and nicknames. 
Drs. White and Sullivan kindly 
point out that  ”RNA-activated 
protein kinase,” or PKR, is the 
enzyme formerly known as DAI, 
p 68 kinase, PKds, or PlIeIF-20: 
protein kinase. Now we know 
where pop singer “Prince” took 
his cue! 
Jargon is an inevitable part of 
hard science, and is not unique 
to molecular biology. As a physi- 
cian, do you always go straight to 
a VIQ when you suspect a PE, or 
do you rely on the A-a gradient, 
D-dimer, or Duplex? I’ll bet a mo- 
lecular biologist would find that 
baffling. Many of us have expe- 
rienced the same trouble with 
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computer jargon as we have with 
molecular biology. Yet, we find 
ways to make computers work 
for us. My suggestion for molec- 
ular biology nomenclature is to 
step back or  regress when you 
are confronted with a new name, 
abbreviation, or symbol. For ex- 
ample, when I encountered the 
new abbreviation “CPP32” in 
White and Sullivan’s article, my 
first thoughts were of the fretful 
robot in the Star Wars movies. 
After a few minutes of day- 
dreaming, I reoriented myself, 
and realized that remembering 
the specific letters and numbers 
for this molecule was way more 
detail than I needed. Therefore, 
I regressed, thinking: very well, 
CPP32 is a caspase that is 
formed by neurons, and the au- 
thors already told me that cas- 
pases are a type of protease. Pro- 
teases are enzymes that degrade 
other proteins, and that can be 
bad for cell function, and can 
contribute to apoptosis. So, from 
now on when I see CPP32, I’m 
thinking-bad neuron enzyme 
that may contribute to apoptosis. 
And when the authors start talk- 
ing about Nedd2, another neu- 
ronally-derived caspase similar 
to CPP32, I’m lumping old Ned 
in with CPP32. In this manner, 
you can simplify the jargon to a 
degree that is appropriate for the 
depth of understanding you need 
in the topic. Remembering all of 
your simplifications can become 
challenging, which brings us  to 
the next suggestion. 
3. Take notes-even i f  you 
don’t know what they mean. Most 
of us are accustomed to taking 
notes when we attend a lecture 
or meeting to aid our recollec- 
tion, decipher a difficult concept, 
or put foreign terms into our own 
words. This practice can be very 
valuable in simplifying a techni- 
cal manuscript. For example, the 
first few times I saw “PARP” in 
the White and Sullivan article, I 
wrote “DNA repair enzyme” next 
to it. Substituting these words 
allowed me to make more sense 
out of the sentences in which 
PARP appeared. Combining the 
tactile sense of writing with the 
visual input of reading is a com- 
mon method for enhancing 
learning. If I later return to 
these notes I have scrawled on 
the margins, they often make no 
sense to me, but the article usu- 
ally does. 
4 .  Focus on the figures. Tex- 
tual descriptions of biomolecular 
processes can lead the reader in 
a downward spiral into the dark- 
ness. In many cases, the refresh- 
ing light that drives the dark- 
ness away is a well-designed 
figure. Since many biomolecular 
processes involve chemical reac- 
tions or cascades, they are often 
conducive to pictorial or sche- 
matic representation. Figures, 
by their nature, and if enforced 
by a good editor, are simplifica- 
tions that can rescue the stray- 
ing reader. Spending a few 
minutes to follow the arrows or 
trace the relationships between 
elements of a figure is usually 
time well spent. Also, the cap- 
tions that describe the figure are 
often concise and simpler to un- 
derstand than the accompanying 
text. 
When it comes to molecular 
biology, you can run, but you 
can’t hide. The head-in-the-sand 
approach does not work well 
when one of your patients pre- 
sents with an Internet search re- 
sult on his or her medical condi- 
tion and asks your opinion on the 
molecular action of a particular 
drug. Even if you decided to 
ditch academic medicine and en- 
ter another career, you will still 
be bombarded by molecular biol- 
ogy information. Descriptions of 
molecular biology concepts as 
they relate to medicine regularly 
appear in newscasts, newspa- 
pers, popular magazines, movies, 
and novels. Your relatives, who 
used to ask about their rheuma- 
tism at  the family reunion, will 
soon be asking how oxidant re- 
actions may be contributing to 
their pain. The only defense will 
be a good offense. Articles such 
as White and Sullivan’s “Apo- 
ptosis” will expand the academic 
physician’s knowledge of molec- 
ular biology, and other basic sci- 
ence disciplines. Happy reading! 
-BRIAN ZINK, MD, Section of 
Emergency Medicine, Depart- 
ment of Surgery, University of 
Michigan, Ann Arbor, MI 
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Apoptosis: On the Verge of 
Clinical Relevance 
ver the past few years we 0 have learned a tremendous 
amount about gene expression as 
it relates to apoptosis and to ce- 
rebral ischemia. The process of 
apoptosis, as distinct from ne- 
crotic cell death, involves nuclear 
DNA as the primary target, with 
DNA fragmentation and chro- 
matin condensation by activation 
of endonucleases and caspases. 
In apoptosis, there is preserva- 
tion of membrane structures and 
cytoplasmic organelles. Necrosis, 
on the other hand, is character- 
ized by lysis of membranes and 
destruction of cytoplasmic organ- 
elles with swelling of mitochon- 
dria and Golgi apparatus. 
The apoptotic mode of cell 
death in the context of experi- 
mental cerebral ischemia in- 
volves several steps between the 
initial ischemia/hypoxic insult 
and frank neuronal death. 
Within this cell death cascade, 
